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ClonesOxacillin is an alternative for the treatment of Staphylococcus spp. infections; however, resistance to this drug
has become a major problem over recent decades. The main objective of this study was to epidemiologically
characterize coagulase-negative staphylococci (CoNS) strains recovered from blood of patients hospitalized in
a Brazilian teaching hospital. Oxacillin resistance was analyzed in 160 strains isolated from blood culture
samples by phenotypic methods, detection of themecA gene, and determination of intermediate sensitivity to
vancomycin on brain heart infusion agar supplemented with 4 and 6 μg/mL vancomycin. In addition,
characterization of the epidemiological proﬁle by staphylococcal cassette chromosome mec (SCCmec) typing
and clonal analysis by pulsed-ﬁeld gel electrophoresis (PFGE) were performed. The mecA gene was detected
in 72.5% of the isolates. Methicillin-resistant CoNS isolates exhibited the highest minimum inhibitory
concentrations and multiresistance when compared to methicillin-susceptible CoNS strains. Typing classiﬁed
32.8% of the isolates as SCCmec I and 50% as SCCmec III. PFGE typing of the SCCmec III Staphylococcus
epidermidis isolates identiﬁed 6 clones disseminated in different wards that persisted from 2002 to 2009. The
high oxacillin resistance rates found in this study and clonal dissemination in different wards highlight the
importance of good practices in nosocomial infection control and of the rational use of antibiotic therapy in
order to prevent the dissemination of these clones.: +55-14-3815-3744.
ouza da Cunha).
l rights reserved.© 2013 Elsevier Inc. All rights reserved.Coagulase-negative staphylococci (CoNS) isolates are usually
etiologic agents of catheter-related bloodstream infections. Oxacillin
resistance rates are currently high among CoNS, a fact that has
become a major problem in the treatment of these infections since
multiresistance is frequent and few therapeutic alternatives are
available. High resistance rates ranging from 66 to 95% are reported
for blood culture isolates (Cuevas et al., 2008; Natoli et al., 2009,
Bouchami et al., 2011).
The most frequent oxacillin resistance mechanism is the presence
of the mecA gene. This gene is carried by a mobile genetic element,
known as the staphylococcal cassette chromosome mec (SCCmec).
Eleven SCCmec types are known so far, which differ in their genetic
composition. SCCmec typing is a useful epidemiological tool (Machado
et al., 2007) since the prevalence of the different types varies between
hospital and community environments. Some of these types carry
genes that confer resistance to multiple antibiotics such as beta-
lactams, macrolides, lincosamines, streptogramins, aminoglycosides,and tetracycline. Hence, when a bacterial cell acquires this SCCmec, it
also acquires a multidrug resistance phenotype (Ito et al., 2003).
In view of the high rates of oxacillin resistance and the emergence
of resistance to other antimicrobials such as vancomycin, knowledge
of the epidemiology of infections caused by Staphylococcus spp. is of
the utmost importance. Over the past few years, molecular tools have
been used in epidemiological studies with good results. Therefore, the
aim of the present study was to epidemiologically characterize CoNS
isolated from patients with bacteremia who were hospitalized in a
Brazilian teaching hospital.
One hundred sixty CoNS isolates stored in the culture collection of
the Department of Microbiology and Immunology, Botucatu School of
Medicine (BSM), Universidade Estadual Paulista (UNESP), were
studied. The strains were isolated between 2002 and 2009 from
blood cultures of patients hospitalized in different wards of BSM-
UNESP, Brazil.
The simpliﬁed scheme proposed by Cunha et al. (2004) was used for
the identiﬁcation of CoNS. Isolates that were not identiﬁed as
Staphylococcus epidermidis were submitted to genotypic identiﬁcation
using primers comprising conserved sequences adjacent to the 16S and
23S genes according to the protocols of Barry et al (1991) and Couto
et al (2001). The following international reference strains were used as
Table 1
Determination of oxacillin susceptibility in coagulase-negative staphylococci isolates by phenotypic and genotypic methods
PCR Phenotypic methods
Disk diffusion
Oxacillin Cefoxitin Screening E-test
S R S R S R S R
N % N % N % N % N % N % N % N %
mecA+ (n = 116) 1 0.9 115 99.1 0 0 116 100 6 5.2 110 94.8 1 0.9 115 99.1
mecA− (n = 44) 40 90.9 4 9.1 40 90.9 4 9.1 41 93.2 3 6.8 40 90.9 4 9.1
S = oxacillin-sensitive isolate; R = oxacillin-resistant isolate.
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49325), Staphylococcus caprae (ATCC 35538), S. epidermidis (ATCC
12228), Staphylococcus haemolyticus (ATCC 29970), Staphylococcus
hominis subsp. novobiosepticus (ATCC 700237), Staphylococcus
saprophyticus (ATCC 15305), Staphylococcus schleiferi subsp. schleiferi
(ATCC 43808), Staphylococcus xylosus (ATCC 29979), and Staphylococ-
cus warneri (ATCC 10209).
Susceptibility to oxacillin was tested by the agar disk diffusion
method using oxacillin (1 μg) and cefoxitin (30 μg) disks and by
screening onMueller-Hinton agar supplementedwith 4 μg/mL oxacillin
and 4% NaCl (CLSI, 2011). Staphylococcus aureus ATCC 25923 (oxacillin
sensitive, mecA gene negative) and ATCC 33591 (oxacillin resistant,
mecA gene positive) were used as controls in all experiments.
PCR for detection of themecA gene was performed as described by
Murakami et al. (1991). The SCCmec type of CoNS was determined
using the multiplex PCR method modiﬁed by Machado et al. (2007).
S. epidermidis and S. haemolyticus isolates were typed by pulsed-ﬁeld
gel electrophoresis (PFGE) according to the protocol modiﬁed by
McDougal et al. (2003). International clones kindly provided by Dr
Antonio Carlos Campos Pignatari, Laboratório Especial de Microbio-
logia Clínica, Disciplina de Infectologia, Universidade Federal de São
Paulo/Escola Paulista de Medicina, and Dr Agnes Marie Sá Figueiredo,
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia
Prof. Paulo de Góes, Brazil, were used as controls.
The E-test was used to determine the in vitro susceptibility of the
CoNS isolates to the following drugs: oxacillin, netilmicin, erythro-
mycin, sulfamethoxazole-trimethoprim, and vancomycin. The iso-
lates were classiﬁed as sensitive or resistant according to
breakpoints (μg/mL) recommended by the CLSI (2011). In the
Results section, isolates presenting intermediate levels were consid-
ered to be resistant. Isolates exhibiting minimum inhibitory
concentrations (MIC) for vancomycin ≥2 μg/mL by the E-test were
evaluated regarding vancomycin heteroresistance. This heteroresis-
tance was analyzed by the modiﬁed E-test method (macromethod)
according to the protocol described by Walsh et al (2001) and by
screening on BHI agar supplemented with 4 and 6 μg/mL
vancomycin (CLSI, 2011).
In this study, the strains isolated from the wards of BSM-UNESP
were divided into 7 complexes according to specialty: Internal
Medicine Wards, Surgery Wards, Pediatric Wards, Gynecology and
Obstetrics, Emergency Room, Intensive Care Units, and other wards.Table 2
MIC for oxacillin and vancomycin in coagulase-negative staphylococci
CoNS Oxacillin
No. of isolates according to MIC range μg/mL
0.023–0.094 0.125–0.75 0.94–
S. epidermidis 14 20 38
S. haemolyticus 4 0 4
S. hominis subsp. novobiosepticus 1 3 9
S. saprophyticus 1 3 3
S. capitis subsp. urealyticus 0 2 3Of the 160 isolates analyzed, 111 were identiﬁed as S. epidermidis,
followed by S. haemolyticus (n= 16), S. hominis subsp. novobiosepticus
(n= 13), S. saprophyticus (n= 9), S. capitis subsp. urealyticus (n= 5),
S. schleiferi subsp. schleiferi (n = 3), and S. xylosus, S. warneri, and
S. caprae with 1 isolate each. Oxacillin resistance was detected by the
oxacillin disk diffusion method in 119 (73.8%) isolates and by the
cefoxitin disk method in 120 (75%) (Table 1). Therefore, 1 isolate was
identiﬁed as oxacillin resistant by the cefoxitin diskmethod but not by
the oxacillin disk method. The test was repeated since the E-test
corroborated the cefoxitin disk result, and this result was conﬁrmed.
The mecA gene was detected in 116 isolates (72.5%). The highest
frequency of the gene was observed among S. haemolyticus strains,
with 12 (75%) positive isolates, followed by S. epidermidis with 82
(70.7%) positive isolates, S. hominis subsp. novobiosepticus with 9
(7.8%) isolates, S. saprophyticus with 7 (6%) isolates, and S. schleiferi
and S. capitis subsp. urealyticuswith 3 (2.6%) isolates each. Four CoNS
isolates weremecA negative and oxacillin resistant by the phenotypic
methods. These isolates were tested by the disk diffusion method
using amoxicillin-clavulanic acid disks and were found to be sensitive,
a fact suggesting resistance due to hyperproduction of β-lactamase.
Analysis of the CoNS strains by the E-test method revealed 119
(74.4%) isolates that were resistant to oxacillin, 104 (65%) resistant to
erythromycin, only 16 (10%) resistant to netilmicin, and 73 (45.6%)
resistant to trimethoprim-sulfamethoxazole. When the isolates were
divided into methicillin-resistant (MR) CoNS and methicillin-sensi-
tive (MS) CoNS, a large difference was observed between the 2
groups, with a predominance of drug-resistant isolates among those
resistant to oxacillin. The highest resistance rates among MRCoNS
were observed to erythromycin, with 90 (77.6%) isolates, followed by
resistance to trimethoprim-sulfamethoxazole, with 66 (56.9%) iso-
lates, and to netilmicin, with only 15 (12.9%) isolates. High rates of
resistance to erythromycin and trimethoprim-sulfamethoxazole were
observed among S. epidermidis, S. haemolyticus, and S. hominis subsp.
novobiosepticus. Table 2 shows the MIC for oxacillin and vancomycin
according to CoNS species studied.
Nine of 67 isolates with MIC ≥2 μg/mL grown on BHI agar
supplemented with 4 μg/mL vancomycin (S. epidermidis, n = 5;
S. haemolyticus, n = 3; S. capitis, n = 1) and 1 S. epidermidis isolate
were able to grow on BHI agar containing 6 μg/mL vancomycin. All
isolates with MIC ≥2 μg/mL showed no heteroresistance to vanco-
mycin when analyzed by the macromethod.Vancomycin
No. of isolates according to MIC range μg/mL
32 N32–N256 0.38–0.5 0.75–1 1.5–2 3–4
39 1 9 97 4
7 0 6 8 2
0 2 6 5 0
2 1 3 5 0
0 0 2 3 0
Table 3
Distribution of SCCmec types in coagulase-negative staphylococci among ward complexes of the University Hospital, Botucatu School of Medicine, UNESP
SCCmec
Ward complex I II III IV NT Total
N % N % N % N % N % N %
Internal medicine 7 30.4 0 0 14 60.9 1 4.3 1 4.3 23 100
Surgery wards 3 37.5 0 0 4 50 1 12.5 0 0 8 100
Emergency room 17 42.5 3 7.5 15 37.9 1 2.5 4 10 40 100
Pediatric wards 1 11.1 0 0 8 88.9 0 0 0 0 9 100
Gynecology and obstetrics 1 100 0 0 0 0 0 0 0 0 1 100
Intensive care units 5 27.8 0 0 9 50 2 11.1 2 11.1 18 100
Other wards 4 23.5 0 0 8 47.1 2 11.8 3 17.6 17 100
SCCmec NT = non-typable cassette chromosome mec; N = number of isolates.
Internal medicine (dermatology, gastroenterology, internal medicine, intensive care, cardiology, hematology, and pneumology).
Surgery wards (surgery, heart surgery thoracic surgery, gastric surgery, orthopedics, and urology).
Emergency room (emergency room and intensive care emergency room).
Pediatric wards (nursery, pediatric intensive care unit, and neonatal intensive care unit).
Gynecology and obstetrics (gynecology and obstetrics wards).
Intensive care units (intensive care unit, central intensive care unit, and coronary intensive care unit).
Other wards (oncology, infectious and parasitic diseases, neurology, and dialysis).
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(2.6%) as SCCmec II, 58 (50%) as SCCmec III, 7 (6%) as SCCmec IV, and
10 (8.6%) could not be typed by the method used. SCCmec III isolates
predominated in all ward complexes, followed by SCCmec I (Table 3).
MRCoNS isolates typed as SCCmec I and III presented the highest
multidrug resistance rates, with 10 SCCmec I and 32 SCCmec III isolates
being resistant to 2 drugs and 1 SCCmec I isolate and 7 SCCmec III
isolates being resistant to 3 drugs.
Three circulating clones of SCCmec I isolates were detected (Fig. 1).
The clone identiﬁed by letter A comprised 5 isolates circulating in 2003,
2004, 2007, 2008, and 2009. These isolates were from the emergency
room, intensive care units, surgery, and internal medicine complexes.
Five circulating clones of SCCmec III S. epidermidis strains were detected
among the isolates analyzed. Clone A comprised 8 isolates detected in
2003, 2005, 2006, and 2009. These isolateswere from the intensive careFig. 1. Dendrogram obtained for SCCmec type I S. epidermidis isolates generated by Dice/U
proﬁles (SmaI) (similarity ≥80%).units, other wards, emergency room, and internal medicine complexes
(Fig. 2). The clone identiﬁed by letter B comprised 7 isolates detected in
2002 and 2003 in the pediatrics and emergency room complexes. The
S. epidermidis isolates typed as SCCmec IV exhibited a polyclonal proﬁle,
and no prevalent clones were found. Four S. haemolyticus SCCmec I
isolates and 3 SCCmec III isolateswere analyzed by PFGE; however, all of
them showed a polyclonal proﬁle.
The CoNS species that exhibited the highest levels of oxacillin
resistance in the present study were S. haemolyticus, with 75% of
the isolates, followed by S. epidermidis (70.7%) and S. hominis
(69.2%). High rates of oxacillin resistance have been reported for
S. haemolyticus, demonstrating the importance to correctly identify
CoNS species (Kristóf et al., 2011; Stuart et al., 2011).
The levels of resistance to the antimicrobials tested were high. The
highest MIC50 values were observed for erythromycin, with valuesPGMA analysis (Bionumerics; Applied Maths, Sint-Martens-Latem, Belgium) of PFGE
Fig. 2. Dendrogram obtained for SCCmec type III S. epidermidis isolates generated by Dice/UPGMA analysis (Bionumerics; Applied Maths) of PFGE proﬁles (SmaI) (similarity ≥80%).
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was resistant to trimethoprim-sulfamethoxazole, and MIC50 and
MIC90 values were higher in MRCoNS than in MSCoNS, a ﬁnding
demonstrating the association between oxacillin resistance and
multidrug resistance. In the present study, only 12.6% of the isolates
were resistant to netilmicin, indicating this drug as well as other drugs
of the aminoglycoside group as good therapeutic alternatives.
Similarly, Emaneini et al. (2009) found only 21.2% of Staphylococcus
spp. isolates to be resistant to netilmicin. Other authors reported
slightly higher netilmicin resistance rates; however, these values
were much lower than the oxacillin resistance rates seen in CoNS,
again highlighting the importance of this drug as a therapeutic
alternative (Giusti et al., 1999).
Differences in resistance rates to the antimicrobials tested were
observed between MRCoNS and MSCoNS isolates, with a higherprevalence of resistance to 2 and 3 drugs in the MRCoNS group.
Multidrug resistance in MRCoNS strains is related to the presence
of transposons and plasmids inserted in the cassette chromosome
mec, in addition to plasmids that can be transferred among CoNS
species or even between CoNS and S. aureus (Huebner and
Goldmann, 1999). The frequency of MRCoNS isolates at BSM-
UNESP was higher in the emergency room complex, a ﬁnding that
may be related to the conditions of the patients who arrive at
these wards.
The percentage of CoNS isolates typed as SCCmec I and SCCmec III
was high in the present study. These types are usually found in
isolates of hospital origin. The prevalence of SCCmec IV, which is found
in isolates of community origin, was low. However, this type has been
detected since 2003, a fact conﬁrming the presence of this cassette in
hospitals since this year.
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and the presence of SCCmec type I and type III. This ﬁnding can be
explained by the fact that these 2 SCCmec types are found in isolates of
nosocomial origin. Potel et al. (2007) also associated SCCmec III with a
high percentage of resistance to erythromycin and to trimethoprim-
sulfamethoxazole. Although SCCmec IV is not associated with multi-
resistant isolates, in this study, 6 of the 7 isolates typed as SCCmec IV
were resistant to erythromycin, and 4were resistant to trimethoprim-
sulfamethoxazole, indicating the existence of multidrug-resistant
SCCmec IV isolates.
Oxacillin-resistant CoNS isolates are usually treated with vanco-
mycin (Schilling et al., 2011). In this study, isolates exhibiting MIC N2
μg/mL were detected, a ﬁnding indicating a decrease in the
susceptibility of CoNS to vancomycin at BSM-UNESP. A decline in
the susceptibility of CoNS isolates to vancomycin has also been
reported in other studies. Although the frequency of vancomycin
heteroresistance was only 6.3% in the present study, high rates of
heteroresistant Staphylococcus spp. isolates have been reported
(Olivares et al., 2010). This is a matter of concern since it limits
therapeutic alternatives to treat these infections.
In view of the increase in the number of oxacillin-resistant
Staphylococcus spp. isolates and the emergence of heteroresistant
and vancomycin-resistant isolates, it is necessary to study the
disseminations of these isolates in hospitals. In the present study,
18 S. epidermidis SCCmec I isolates and 41 SCCmec III isolates were
typed by PFGE. The results revealed 3 clones of SCCmec I isolates.
The largest clone was present from 2003 to 2009, which may
characterize clonal dissemination of these isolates. Five clones of
SCCmec III isolates were detected. These clones were found in
different wards and have been circulating for several years. The
clone identiﬁed by letter A comprised 5 isolates that showed 100%
similarity, a fact indicating that the same isolate circulated from
2003 to 2009 in different wards. There are reports of the
dissemination and persistence of SCCmec III isolates in different
wards (Klingenberg et al., 2007; Muldrew et al., 2008). The
SCCmec IV S. epidermidis isolates typed showed a polyclonal proﬁle,
which may be related to the community origin of these isolates.
Clonal dissemination of mecA-positive S. haemolyticus strains has
been reported (Yu et al., 2010). However, the S. haemolyticus
isolates exhibited distinct proﬁles, although all of them carried a
hospital-associated cassette chromosome mec. Despite the hetero-
geneity of most CoNS indicating different origins, the present
ﬁndings suggest that particular clones of multidrug-resistant CoNS,
such as the clone of SCCmec III S. epidermidis, may have a common
origin and may persist in the hospital environment for long
periods of time. To a large extent, clonal dissemination is probably
mediated by colonized patients moving between different wards
within the hospital. Multidrug-resistant bacteria are likely to
persist in colonized patients and in hospital staff or in the hospital
environment. However, further prospective studies are needed to
better understand the dissemination mechanisms and to establish
measures that prevent the emergence and dissemination of
these bacteria.
The present results highlight the importance of oxacillin
resistance detection as a marker to choose antimicrobial therapy,
with the observation of multidrug resistance among MRCoNS
isolates and increased susceptibility to other antimicrobials among
MSCoNS isolates. This study found a high prevalence of MRCoNS
clones in the ward complexes and the persistence of these clones
over the years studied. Taken together, these ﬁndings demon-
strate the importance of CoNS as hospital pathogens and the
need for good hospital infection control practices and rational use
of antibiotic therapy in order to prevent the dissemination of
these clones.Acknowledgments
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